8 assets in Brain Glioma

Therapeutic assets addressing Brain Glioma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
g207 Brain Glioma	Pediatric Brain Tumor Consortium	P2	CCC (53)
Mirtazapine Brain Glioma	University of California, Irvine	P2	CCC (53)
Capecitabine Brain Glioma	Northwell Health	P1/2	CCC (48)
Acetazolamide Brain Glioma	University of Chicago	P1	CC (43)
Ad5-yCD Brain Glioma	Henry Ford Health System	P1	CC (43)
ad5-ycd/muttksr39rep-adp adenovirus Brain Glioma	Henry Ford Health System	P1	CC (43)
Cyclophosphamide Brain Glioma	Dana-Farber Cancer Institute	P1	CC (43)
Rqnestin Brain Glioma	Dana-Farber Cancer Institute	P1	CC (43)